qaialdo
nova laboratories ireland limited - spironolaktón - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 a 5.
diphereline s.r. 22,5 mg
ipsen pharma, francúzsko - triptorelín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
diphereline s.r. 3,75 mg
ipsen pharma, francúzsko - triptorelín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
diphereline s.r. 11,25 mg
ipsen pharma, francúzsko - triptorelín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
leuprorelin sandoz 3,6 mg implantát
sandoz pharmaceuticals d.d., slovinsko - leuprorelín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
toletate
zentiva, k.s., Česká republika - leuprorelín - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
enzalutamid sandoz 80 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - enzalutamid - 44 - cytostatica
enzalutamid sandoz 40 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - enzalutamid - 44 - cytostatica